Search Results - "Worland, Peter J."

Refine Results
  1. 1

    Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism by ESCOUBET-LOZACH, Laure, LIN, I-Lin, JENSEN-PERGAKES, Kristen, BRADY, Helen A, GANDHI, Anita K, SCHAFER, Peter H, MULLER, George W, WORLAND, Peter J, CHAN, Kyle W. H, VERHELLE, Dominique

    Published in Cancer research (Chicago, Ill.) (15-09-2009)
    “…Lenalidomide and pomalidomide have both been evaluated clinically for their properties as anticancer agents, with lenalidomide being available commercially. We…”
    Get full text
    Journal Article
  2. 2

    A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer by HENRY, Michael D, SHENGHUA WEN, SILVA, Matthew D, CHANDRA, Sudeep, MILTON, Mark, WORLAND, Peter J

    Published in Cancer research (Chicago, Ill.) (01-11-2004)
    “…MLN2704 is an antibody-chemotherapeutic conjugate designed to target prostate-specific membrane antigen (PSMA). PSMA is a transmembrane receptor whose…”
    Get full text
    Journal Article
  3. 3

    Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells by CARLSON, B. A, DUBAY, M. M, SAUSVILLE, E. A, BRIZUELA, L, WORLAND, P. J

    Published in Cancer research (Chicago, Ill.) (01-07-1996)
    “…Flavopiridol (L86-8275), a N-methylpiperidinyl, chlorophenyl flavone, can inhibit cell cycle progression in either G1 or G2 and is a potent cyclin-dependent…”
    Get full text
    Journal Article
  4. 4

    Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol by CARLSON, B, LAHUSEN, T, SINGH, S, LOAIZA-PEREZ, A, WORLAND, P. J, PESTELL, R, ALBANESE, C, SAUSVILLE, E. A, SENDEROWICZ, A. M

    Published in Cancer research (Chicago, Ill.) (15-09-1999)
    “…Flavopiridol is a novel flavonoid that induces cell cycle arrest at different stages of the cell cycle because of the inhibition of cyclin-dependent kinases…”
    Get full text
    Journal Article
  5. 5

    UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53 by Wang, Qizhi, Fan, Saijun, Eastman, Alan, Worland, Peter J., Sausville, Edward A., O'Connor, Patrick M.

    “…Background: Arrest of the cell cycle in G2 phase following DNA damage helps protect cell viability by allowing time for DNA repair before entry into mitosis (M…”
    Get full text
    Journal Article
  6. 6

    Anticancer antibodies by ROSS, Jeffrey S, GRAY, Karen, GRAY, Gary S, WORLAND, Peter J, ROLFE, Mark

    Published in American journal of clinical pathology (01-04-2003)
    “…The recent clinical and commercial success of anticancer antibodies such as rituximab and trastuzumab has created great interest in antibody-based therapeutics…”
    Get full text
    Journal Article
  7. 7

    Structural Basis for Specificity and Potency of a Flavonoid Inhibitor of Human CDK2, a Cell Cycle Kinase by De Azevedo, Walter Filgueira, Mueller-Dieckmann, Hans-Joachim, Schulze-Gahmen, Ursula, Worland, Peter J., Sausville, Edward, Kim, Sung-Hou

    “…The central role of cyclin-dependent kinases (CDKs) in cell cycle regulation makes them a promising target for studying inhibitory molecules that can modify…”
    Get full text
    Journal Article
  8. 8

    Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients by Henry, Michael D., Silva, Matthew D., Wen, Shenghua, Siebert, Elizabeth, Solin, Edward, Chandra, Sudeep, Worland, Peter J.

    Published in The Prostate (01-12-2005)
    “…Background Prostate cancer bone metastasis is distinguished by the predominance of osteoblastic lesions. This phenotype has been difficult to reproduce in…”
    Get full text
    Journal Article
  9. 9

    Antibody-based therapeutics in oncology by Ross, Jeffrey S, Gray, Karen, Schenkein, David, Greene, Barry, Gray, Gary S, Shulok, Jeanine, Worland, Peter J, Celniker, Abbie, Rolfe, Mark

    Published in Expert review of anticancer therapy (01-02-2003)
    “…The recent clinical and commercial success of anticancer antibodies, such as rituximab (Rituxan®) and trastuzumab (Herceptin®) has created great interest in…”
    Get full text
    Journal Article
  10. 10

    Possible Role for Serine/Threonine Phosphorylation in the Regulation of the Heteroprotein Complex between the hsp90 Stress Protein and the pp60 Tyrosine Kinase by Edward G. Mimnaugh, Peter J. Worland, Luke Whitesell, Leonard M. Neckers

    Published in The Journal of biological chemistry (01-12-1995)
    “…The abundant, cytoplasmic 90-kDa heat-shock protein associates transiently with the Rous sarcoma virus oncogenic protein tyrosine kinase, pp60 , directs its…”
    Get full text
    Journal Article
  11. 11

    The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist (∗) by Kroog, Glenn S., Sainz, Eduardo, Worland, Peter J., Akeson, Mark A., Benya, Richard V., Jensen, Robert T., Battey, James F.

    Published in The Journal of biological chemistry (07-04-1995)
    “…Several guanine nucleotide-binding protein-coupled receptors are known to be rapidly phosphorylated after agonist exposure. In this study we show that the…”
    Get full text
    Journal Article
  12. 12

    Possible Role for Serine/Threonine Phosphorylation in the Regulation of the Heteroprotein Complex between the hsp90 Stress Protein and the pp60v-src Tyrosine Kinase () by Mimnaugh, Edward G., Worland, Peter J., Whitesell, Luke, Neckers, Leonard M.

    Published in The Journal of biological chemistry (01-12-1995)
    “…The abundant, cytoplasmic 90-kDa heat-shock protein associates transiently with the Rous sarcoma virus oncogenic protein tyrosine kinase, pp60v-src, directs…”
    Get full text
    Journal Article
  13. 13

    Radioimmunoassay for the quantitation of lisinopril and enalaprilat by Worland, P J, Jarrott, B

    Published in Journal of pharmaceutical sciences (01-05-1986)
    “…A sensitive radioimmunoassay (RIA) capable of measuring either lisinopril (1-[N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl] -L-proline) or enalaprilat…”
    Get more information
    Journal Article
  14. 14

    Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells by HAMPTON, L. L, WORLAND, P. J, YU, B, THORGEIRSSON, S. S, HUGGETT, A. C

    Published in Cancer research (Chicago, Ill.) (01-12-1990)
    “…Clonal cell lines were derived from rat liver epithelial cells following their transformation with either v-raf or v-raf/v-myc. Cells transformed with v-raf…”
    Get full text
    Journal Article
  15. 15

    Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275 by Losiewicz, M D, Carlson, B A, Kaur, G, Sausville, E A, Worland, P J

    “…L86-8275 [(-) cis-5,7-dihydroxy-2-(2-chlorophenyl)-8[4-(3-hydroxy-1- methyl)-piperidinyl]-4H-benzopyran-4-one] directly inhibits immunoprecipitated Cdc2 kinase…”
    Get more information
    Journal Article
  16. 16

    Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue by Seynaeve, C M, Kazanietz, M G, Blumberg, P M, Sausville, E A, Worland, P J

    Published in Molecular pharmacology (01-06-1994)
    “…UCN-01 (7-hydroxystaurosporine) has been demonstrated to be a potent inhibitor of tumor cell growth both in cell culture and with in vivo xenograft models. The…”
    Get more information
    Journal Article
  17. 17

    Structure-activity relationship studies of flavopiridol analogues by Murthi, K K, Dubay, M, McClure, C, Brizuela, L, Boisclair, M D, Worland, P J, Mansuri, M M, Pal, K

    Published in Bioorganic & medicinal chemistry letters (15-05-2000)
    “…Cyclin dependent kinases (CDKs) along with the complementary cyclins form key regulatory checkpoint controls on the cell cycle. Flavopiridol is a synthetic…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 in human breast carcinoma cells by SEYNAEVE, C. M, STETLER-STEVENSON, M, SEBERS, S, KAUR, G, SAUSVILLE, E. A, WORLAND, P. J

    Published in Cancer research (Chicago, Ill.) (01-05-1993)
    “…UCN-01 is a derivative of staurosporine, initially developed as a potentially selective inhibitor of the Ca(2+)- and phospholipid-dependent protein kinase C,…”
    Get full text
    Journal Article